Where tomorrow lives.
Imagine a tomorrow where experiencing and appreciating what life has to offer is a daily occurrence. More weddings, more sunsets, more laughter, and most importantly, more living.
With uncompromising dedication and a spirit of innovation born from a sense of compassion, we strive for bold diagnostic solutions that may lead to better outcomes for patients across their journeys.
At Oncocyte™, we focus on tomorrow to help deliver better cancer care today.
Products
Our mission is to develop a family of tests to provide physicians and their patients actionable answers at critical decision points across the cancer care continuum.
IO
DetermaIO™
(for research use only)
Dx
DetermaDx™
(in development)
A liquid biopsy test to rule out malignancy in lung nodules
About Us
At Oncocyte, we believe that empowering physicians with bold and innovative diagnostic solutions may lead to better outcomes for their patients.
Investors
Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the lung cancer care continuum, with the goal of improving patient outcomes by accelerating and optimizing diagnosis and treatment.
